This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The clinical features, pathologic changes, and immune repertoire in a remarkable case of chronic varicella-zoster virus (VZV) ganglioneuritis without rash are described.
Acknowledgments
Acknowledgment: Permission for the studies described in this manuscript was obtained from the patient's wife. The authors thank Marina Hoffman, who reviewed the manuscript for errors in grammar, punctuation, spelling, readability, clarity, and accuracy; and Lori DePriest for word processing and formatting the manuscript.
Footnotes
Study funding: Public Health Service grants AG032958 (D.G., R.J.C.), AG006127 (D.G.), NS082228 (R.J.C.). Dr. Birlea was supported by Training Grant NS007321 to Dr. Gilden from the National Institutes of Health.
Author contributions: M. Birlea: drafting/revising the manuscript for content, including medical writing for content; study concept/design; analysis and interpretation of data; contribution of vital reagents. M. Nagel: drafting/revising the manuscript for content, including medical writing for content; study concept/design; analysis and interpretation of data; contribution of vital reagents. N. Khmeleva: acquisition of data. A. Choe: acquisition of data. B.K. DeMasters: interpretation of data. R. Hevner: analysis of data; acquisition of data. P. Boyer: acquisition and analysis of data. K. Lear-Kaul: acquisition and analysis of data. N. Bos: acquisition of data. M. Wellish: acquisition of data. R.J. Cohrs: drafting/revising the manuscript for content, analysis and interpretation of data; contribution of vital reagents/tools/patents; obtaining funding. D. Gilden: drafting/revising the manuscript for content, including medical writing for content; study concept/design; acquisition, analysis, and interpretation of data; contribution of vital reagents, obtaining funding.
Disclosure: M. Birlea was supported by training grant NS007321 to Dr. Gilden from NIH. M. Nagel receives research support from NIH research grant NS067070. N. Khmeleva, A. Choe, B. Kleinschmidt-DeMasters, R. Hevner, P. Boyer, K. Lear-Kaul, N. Bos, and M. Wellish report no disclosures. R. Cohrs receives research support from NIH research grant NS082228 and AG03258. D. Gilden receives research support from NIH research grants AG006127 and AG03258. Dr. Gilden serves as Senior Associate Editor for the Journal of Neurovirology and on the editorial boards of In Vivo, Journal of Virology, Scientific American, Virus Genes, and Neurology. Go to Neurology.org for full disclosures.
- Received June 27, 2013.
- Accepted in final form August 30, 2013.
- © 2013 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
